# Contribute to NootropicsWiki

To contribute, click "Improve this page" in the bottom right of the page you would like to contribute to and follow the guide strictly.

I have yet to devise a good system to allow contributions for pages that do not currently exist. Let me know via discord (MattNZ) if you have any suggestions.

Remember, stick to the facts. 
If there is an unknown anywhere, just remove it.

### The guide/template:
```
# CommonName

---

### IUPAC
IUPACName

### Class
Nootropic / Stimulant / Anxiolytic / Eugeroic / Etc

<!--Analogues: -->
<!--Prodrugs: -->

### Mechanism of Action

Insert a concise and informative description about the Mechanism of Action here.

### ROA & Dosages (Low-High)
<!-- Only insert common routes of administration and known, safe dosage ranges -->
Oral: 00-000mg
Sublingual: 00-000mg
IntraNasal: 0-00mg
Topical: 0-00mg

### Estimated Effect Duration
<!-- Only insert common RoAs and known effect durations -->
Oral: 6-10h
IntraNasal: 4-8h

## Studies

#### Has X effect
- [Source](InsertLinkToStudy)
- [Source](InsertLinkToStudy)

#### Reduces Y
- [Source](InsertLinkToStudy)

#### Improves Z
- [Source](InsertLinkToStudy)

#### Anti-X
- [Source](InsertLinkToStudy)

<!--### Interactions-->
```

### Example:
```
# Bromantane

---

### IUPAC
N-(4-bromophenyl)adamantan-2-amine

### Class
Nootropic / Stimulant / Anxiolytic

<!--Analogues: -->
<!--Prodrugs: -->

### Mechanism of Action

Bromantane's mechanism of action primarily involves enhancing dopamine synthesis through upregulation of key enzymes tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AAAD) via indirect genomic pathways. Bromantane elevates cAMP response element-binding protein (CREB), which disinhibits TH (usually blocked by dopamine), leading to increased dopamine synthesis.

Additionally, Bromantane is hypothesized to act as a Kir2.1 channel inhibitor, stabilizing indirect pathway medium spiny neurons (IMSNs) and preventing aberrant synaptogenesis. Moreover, Bromantane reduces inflammatory cytokines and inhibits histone deacetylase (HDAC), upregulating neurotrophins like brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF), contributing to its neuroprotective effects.

### ROA & Dosages (Low-High)
Oral: 50-200mg
Sublingual: 25-100mg
IntraNasal: 9-36mg

### Estimated Effect Duration
Oral: 6-10h
IntraNasal: 4-8h

## Studies

#### Moderate dopaminergic effects after discontinuation
- [Source](https://pubmed.ncbi.nlm.nih.gov/11109517/)
- [Source](https://pubmed.ncbi.nlm.nih.gov/19491814/)
- [Source](https://pubmed.ncbi.nlm.nih.gov/21322821/)

#### Reduces anxiety
- [Source](https://pubmed.ncbi.nlm.nih.gov/21322821/)

#### Improves physical endurance
- [Source](https://pubmed.ncbi.nlm.nih.gov/10934588/)

#### Enhances learning
- [Source](https://pubmed.ncbi.nlm.nih.gov/10998997/)

#### Improves sex-drive
- [Source](https://pubmed.ncbi.nlm.nih.gov/15341065/)

#### Elevates CREB
- [Source](https://www.sciencedirect.com/science/article/abs/pii/S0028390807002109)

#### Reduces inflammatory cytokines
- [Source](https://pubmed.ncbi.nlm.nih.gov/22288152/)

#### Inhibits HDAC
- [Source](https://sci-hub.se/https://pubmed.ncbi.nlm.nih.gov/22235395/)

#### Neurotrophin-mediated sensitizing properties
- [Source](https://sci-hub.se/https://link.springer.com/article/10.1007%2Fs10517-012-1516-z

#### Anti-fibrotic
- [Source](https://www.globenewswire.com/news-release/2019/07/31/1894580/0/en/Algernon-Pharmaceuticals-Announces-Russian-Athletic-Performance-Enhancing-Drugs-Bemethyl-NP-135-and-Bromantane-NP-160-Exhibited-Potent-Anti-Fibrotic-Activity-in-NASH-and-CKD-Studie.html)

#### Protective effects on mitochondria and cellular membranes
- [Source](https://pubmed.ncbi.nlm.nih.gov/9929819/)

<!--### Interactions-->
```